POSACONAZOLE DELAYED-RELEASE

11286 reported adverse events

Drug classes: Azole Antifungal [EPC]

These side effects are most commonly reported by patients taking POSACONAZOLE DELAYED-RELEASE:

# Side effect Count
0 DRUG INEFFECTIVE 1343
1 OFF LABEL USE 1260
2 FEBRILE NEUTROPENIA 917
3 DRUG INTERACTION 838
4 PYREXIA 679
5 NEUTROPENIA 675
6 PRODUCT USE IN UNAPPROVED INDICATION 629
7 DEATH 592
8 PNEUMONIA 501
9 THROMBOCYTOPENIA 434
See all common reactions for POSACONAZOLE DELAYED-RELEASE

POSACONAZOLE DELAYED-RELEASE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PROTOTHECOSIS 34 0.3617
1 PSEUDOALDOSTERONISM 64 0.3232
2 FUSARIUM INFECTION 105 0.1500
3 MICROSPORIDIA INFECTION 50 0.1425
4 SCEDOSPORIUM INFECTION 79 0.1119
5 DIFFERENTIATION SYNDROME 57 0.0777
6 PULMONARY MUCORMYCOSIS 37 0.0701
7 MUCORMYCOSIS 171 0.0657
8 ACUTE MYELOID LEUKAEMIA RECURRENT 138 0.0642
9 CEREBRAL ASPERGILLOSIS 35 0.0569
See all enriched reactions for POSACONAZOLE DELAYED-RELEASE